Topics

Synlogic Announces First Quarter 2019 Conference Call and Webcast

16:05 EDT 2 May 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company applying synthetic biology to beneficial microbes to develop novel, living medicines, announced today that the Company will release its first quarter 2019 financial ...

Other Sources for this Article

Media Contact:
Synlogic
Courtney Heath
617-872-2462
courtney@scientpr.com

Investor Contact:
Synlogic
Elizabeth Wolffe, Ph.D.
617-207-5509
liz@synlogictx.com

NEXT ARTICLE

More From BioPortfolio on "Synlogic Announces First Quarter 2019 Conference Call and Webcast"

Quick Search

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Hepatology
Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...